Direct injection of immature dendritic cells into irradiated tumor induces efficient antitumor immunity

International Journal of Cancer

Volumn 109, Issue 5, 2004, Pages 685-690

  Kim, Kwang Woon ^a,c   Kim, Sun Hee ^a   Shin, Jin Gue ^a   Kim, Gui Sook ^a   Son, Young Ok ^a   Park, Soon Won ^a   Kwon, Byung Hyun ^a   Kim, Dong Won ^a   Lee, Chang Hun ^a   Sol, Mee Young ^a   Jeong, Min Ho ^a,b   Chung, Byung Seon ^a   Kang, Chi Dug ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Dong A University   (South Korea)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dendritic cell; Immunotherapy; Radioimunotherapy; Radiotherapy

Indexed keywords

DNA VACCINE; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADVANCED CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER IMMUNIZATION; CANCER RADIOTHERAPY; CELL MATURATION; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; FEMALE; GENE FUSION; IMMUNE RESPONSE; INJECTION; IONIZING RADIATION; IRRADIATION; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DENDRITIC CELLS; FEMALE; FIBROSARCOMA; INJECTIONS, INTRALESIONAL; LIPOPOLYSACCHARIDES; LYMPHOMA; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; RADIOIMMUNOTHERAPY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 12144288198     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20036     Document Type: Article

References (36)

1. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
2. Fong L, Engleman EG. Dendritic cells in cancer immunotherapy. Annu Rev Immunol 2000;18:245-73.
3. Nouri-Shirazi M, Banchereau J, Fay J, Palucka K. Dendritic cell based tumor vaccines. Immunol Lett 2000;74:5-10.
4. Bremers AJ, Parmiani G. Immunology and immunotherapy of human cancer: present concepts and clinical developments. Crit Rev Oncol Hematol 2000;34:1-25.
5. Moingeon P. Cancer vaccines. Vaccine 2001;19:1305-26.
6. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
7. Albert ML, Pearce SF, Francisco LM, Sauter B, Roy P, Silverstein RL, Bhardwaj N. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 1998;188:1359-68.
8. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class 1-restricted CTLs. Nature 1998;392:86-9.
9. Shaif-Muthana M, McIntyre C, Sisley K, Rennie I, Murray A. Dead or alive: immunogenicity of human melanoma cells when presented by dendritic cells. Cancer Res 2000;60:6441-7.
10. + T cells for efficient tumor cell lysis. Cancer Res 2000;60:4446-52.
11. Hoffmann TK, Meidenbauer N, Dworacki G, Kanaya H, Whiteside TL. Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells. Cancer Res 2000;60:3542-9.
12. Russo V, Tanzarella S, Dalerba P, Rigatti D, Rovere P, Villa A, Bordignon C, Traversari C. Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class 1-restricted T cell response. Proc Natl Acad Sci USA 2000;97:2185-90.
13. Labarriere N, Bretaudeau L, Gervois N, Bodinier M, Bougras G, Diez E, Lang F, Gregoire M, Jotereau F. Apoptotic body-loaded dendritic cells efficiently cross-prime cytotoxic T lymphocytes specific for NA17-A antigen but not for Melan-A/MART-1 antigen. Int J Cancer 2002;101:280-6.
14. Zhivotovsky B, Joseph B, Orrenius S. Tumor radiosensitivity and apoptosis. Exp Cell Res 1999;248:10-7.
15. Kaufmann SH, Earnshaw WC. Induction of apoptosis by cancer chemotherapy. Exp Cell Res 2000;256:42-9.
16. Mow BM, Blajeski AL, Chandra J, Kaufmann SH. Apoptosis and the response to anticancer therapy. Curr Opin Oncol 2001;13:453-62.
17. Zhivotovsky B, Orrenius S. Defects in the apoptotic machinery of cancer cells: role in drug resistance. Semin Cancer Biol 2003;13:125-34.
18. Lambert LA, Gibson GR, Maloney M, Barth RJ Jr. Equipotent generation of protective antitumor immunity by various methods of dendritic cell loading with whole cell tumor antigens. J Immunother 2001;24:232-6.
19. Larsson M, Fonteneau JF, Bhardwaj N. Dendritic cells resurrect antigens from dead cells. Trends Immunol 2001;22:141-8.
20. Tarte K, Klein B. Dendritic cell-based vaccine: a promising approach for cancer immunotherapy. Leukemia 1999;13:653-63.
21. Ross GM. Induction of cell death by radiotherapy. Endocr Relat Cancer 1999;6:41-4.
22. Gorelik E, Begovic M, Duty L, Herberman RB. Effect of ultraviolet irradiation on MCA-102 tumor cell immunogenicity and sensitivity to tumor necrosis factor. Cancer Res 1991;51:1521-8.
23. Ciernik IF, Romero P, Berzofsky JA, Carbone DP. Ionizing radiation enhances immunogenicity of cells expressing a tumor-specific T-cell epitope. Int J Radiat Oncol Biol Phys 1999;45:735-41.
24. Friedman EJ. Immune modulation by ionizing radiation and its implications for cancer immunotherapy. Curr Pharm Des 2002;8:1765-80.
25. Nikitina EY, Gabrilovich DI. Combination of gamma-irradiation and dendritic cell administration induces a potent antitumor response in tumor-bearing mice: approach to treatment of advanced stage cancer. Int J Cancer 2001;94:825-33.
26. Lotze MT. Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer. Ann Surg 1997;226:1-5.
27. Candido KA, Shimizu K, McLaughlin JC, Kunkel R, Fuller JA, Redman BG, Thomas EK, Nickoloff BJ, Mule JJ. Local administration of dendritic cells inhibits established breast tumor growth: implications for apoptosis-inducing agents. Cancer Res 2001;61:228-36.
28. Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000;191:411-6.
29. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999;5:1249-55.
30. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000;191:423-34.
31. Rovere P, Vallinoto C, Bondanza A, Crosti MC, Rescigno M, Ricciardi-Castagnoli P, Rugarli C, Manfredi AA. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol 1998;161:4467-71.
32. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappaB pathway. Int Immunol 2000;12:1539-46.
33. Kotera Y, Shimizu K, Mule JJ. Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization. Cancer Res 2001;61:8105-9.
34. Tong Y, Song W, Crystal RG. Combined i.t. injection of bone marrow-derived dendritic cells and systemic chemotherapy to treat pre-existing murine tumors. Cancer Res 2001;61:7530-5.
35. Tanaka F, Yamaguchi H, Ohta M, Mashino K, Sonoda H, Sadanaga N, Inoue H, Mori M. Intratumoral injection of dendritic cells after treatment of anticancer drugs induces tumor-specific antitumor effect in vivo. Int J Cancer 2002;101:265-9.
36. Yu B, Kusmartsev S, Cheng F, Paolini M, Nefedova Y, Sotomayor E, Gabrilovich D. Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer. Clin Cancer Res 2003;9:285-94.